SCHEMBL2182908

SCHEMBL2182908

Cc1cc(O)n2c(c1)nc1ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.42
ALDH1A1 P00352 9/20 0.42
HPGD P15428 6/20 0.42
POLB P06746 5/20 0.42
GAA P10253 4/20 0.42
HSD17B10 Q99714 3/20 0.42
MEN1 O00255 2/20 0.42
CASP1 P29466 2/20 0.42
KMT2A Q03164 2/20 0.42
THRB P10828 1/20 0.42
CASP7 P55210 1/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
MAPK1 P28482 1/20 0.42
MAPT P10636 6/20 0.41
TP53 P04637 3/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
PDE2A O00408 2/20 0.41
PDE10A Q9Y233 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12395170 0.77 KDM4E (0.55) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL2163340 0.76 ADORA2A (0.45) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL9362915 0.72 CSNK1A1 (0.44) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL26078910 0.71 CHEK1 (0.53) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL2164369 0.69 KDM4E (0.37) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL24553487 0.69 PTPN2 (0.51) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL17993475 0.69 KDM4E (0.54) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL19380387 0.69 KDM4E (0.47) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL5579490 0.68 PKM (0.47) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL4567509 0.68 KDM4E (0.73) KDM4EALDH1A1HPGDPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110165220-A1 DRUGS TO PREVENT HPV INFECTION WISCONSIN ALUMNI RESEARCH FOUNDATION 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165220-A1 DRUGS TO PREVENT HPV INFECTION VHL, PHF13, CDKN1A KDM4E 101/4885ALDH1A1 458/4885HPGD 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.